August 29th 2025, 1:00pm
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about understanding Gleason Score and prostate cancer risk.
August 28th 2025, 1:00pm
Patients with breast cancer receiving antibody-drug conjugates after chemo can generally expect milder side effects compared with their previous treatment.
August 27th 2025, 8:00pm
Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers.
August 27th 2025, 7:00pm
For many women facing cancer, having a female oncologist can bring an added sense of support and understanding, according to Dr. Tran Ho.
August 27th 2025, 1:00pm
FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results.
August 26th 2025, 8:00pm
Dr. William Audeh explains how treatment decisions for breast cancer can be informed by a patient’s ultra-low, low or high genomic risk status.
August 26th 2025, 1:00pm
Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about patients’ need to find reliable sources of information.
August 24th 2025, 6:00pm
An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients with pancreatic or colorectal cancers.
August 21st 2025, 1:00pm
The GIST treatment landscape has shifted in recent years due to the emergence of new therapies, many of which patients should be aware of.
August 20th 2025, 8:00pm
When a family member receives a diagnosis, it can present emotional challenges for children.
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients
Expert Explains Need for Better Outcomes in Resectable Lung Cancer